Concepedia

Publication | Closed Access

PRELIMINARY EXPERIENCE WITH ALEMTUZUMAB (CAMPATH-1H) AND LOW-DOSE TACROLIMUS IMMUNOSUPPRESSION IN ADULT LIVER TRANSPLANTATION

DOI

119

Citations

11

References

2004

Year

Andreas G. Tzakis, Panagiotis Tryphonopoulos, Tomoaki Kato, Seigo Nishida, David Levi, Juan R. Madariaga, Jeffrey J. Gaynor, Werviston De Faria, Arie Regev, Violet Esquenazi,
Transplantation

Abstract

C1H and low-dose Tac seems to be at least as effective as our standard Tac and steroids regimen in preventing acute rejection in adult liver allotransplantation with less renal toxicity and less use of maintenance steroids.

References

YearCitations

Page 1